Karagiannis T, Avgerinos I, Liakos A et al (2022) Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis
GLP-1 Medications: Safe Starting Doses Medications like Semaglutide (Wegovy, Ozempic) and Tirzepatide (Mounjaro, Zepbound) are widely used for weight management and type 2 diabetes care
Note that the therapeutic indication for all of these drugs is for type 2 diabetes, with the exception of Wegovy (2.4 mg/week of semaglutide by subcutaneous injection), which was recently approved for weight loss
D., Sakowski, S
the trials were small (ranging from 20 to 193 subjects) and their design was so different that results could not be generalized
Glow from Within 35% OFF IV Vitamin Therapy This powerful antioxidant drip works at a cellular level to brighten skin, reduce hyperpigmentation, and give you that coveted glass skin glow